Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma in Situ of the Breast

Breast Journal

Volumn 22, Issue 1, 2016, Pages 63-74

  Rivera, Ronald ^a   Banks, Alexandra ^b   Casillas Lopez, America ^c   Rashtian, Afshin ^d   Lewinsky, Bernie ^b   Sheth, Pulin ^c   Hovannesian Larsen, Linda ^c   Brousseau, David ^b   Iyengar, Geeta ^e   Holmes, Dennis R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Women's Health   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Cancer Center Riverside Community Hospital   (United States)

^e Medical Imaging Center of Southern California   (United States)

Author keywords

breast cancer; ductal carcinoma in situ; intraoperative radiotherapy; IORT; partial breast irradiation

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIGITAL MAMMOGRAPHY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; LOCAL THERAPY; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; MINIMALLY INVASIVE PROCEDURE; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; RADIATION EXPOSURE; RADIATION ONCOLOGIST; RECURRENCE RISK; REOPERATION; TUMOR VOLUME; WIDE EXCISION; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME;

CONTRAST MEDIUM;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84956763892     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12516     Document Type: Article

References (47)

1. Fisher ER, Dignam J, Tan-Chiu E, et al,. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol B-17: intraductal carcinoma. Cancer 1999; 86: 429-38.
2. National Comprehensive Cancer Network. National comprehensive cancer network guidelines for breast cancer. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#breast. Updated January 2014 (accessed May 1, 2014).
3. Veronesi U, Marubini E, Mariani L, et al,. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001; 12: 997-1003.
4. Bartelink H, Horiot JC, Poortmans PM, et al,. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25: 3259-65. doi:JCO.2007.11.4991.
5. Clark RM, Wilkinson RH, Mahoney LJ, Reid JG, MacDonald WD,. Breast cancer: a 21 year experience with conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1982; 8: 967-79. doi:0360-3016(82)90163-8.
6. Kurtz JM, Spitalier JM, Amalric R, et al,. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 1990; 18: 87-93. doi:0360-3016(90)90271-K.
7. Wilkinson JB, Beitsch PD, Shah C, et al,. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of william beaumont hospital and american society of breast surgeon MammoSite registry trial data. Int J Radiat Oncol Biol Phys 2013; 85: 1179-85. doi: 10.1016/j.ijrobp.2012.10.010.
8. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M,. Five-year outcome of patients classified using the american society for radiation oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the american society of breast surgeons MammoSite registry trial. Cancer 2010; 116: 4677-85. doi: 10.1002/cncr.25383.
9. Kong L, Cheng J, Ding X, et al,. Efficacy and safety of accelerated partial breast irradiation after breast-conserving surgery: a meta-analysis of published comparative studies. Breast J 2014; 20: 116-24. doi: 10.1111/tbj.12226.
10. American Society of Breast Surgeons. ASBS consensus statement for accelerated partial breast irradiation. Available at: https://www.breastsurgeons.org/statements/PDF-Statements/APBI.pdf. Updated August 15, 2011 (accessed May 15, 2014).
11. Smith BD, Arthur DW, Buchholz TA, et al,. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg 2009; 209: 269-77. doi: 10.1016/j.jamcollsurg.2009.02.066.
12. Shah C, Vicini F, Wazer DE, Arthur D, Patel RR,. The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy 2013; 12: 267-77. doi: 10.1016/j.brachy.2013.02.001.
13. Polgar C, Van Limbergen E, Potter R, et al,. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen De Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group based on clinical evidence (2009). Radiother Oncol 2010; 94: 264-73. doi: 10.1016/j.radonc.2010.01.014.
14. Presley CJ, Soulos PR, Herrin J, et al,. Patterns of use and short-term complications of breast brachytherapy in the national Medicare population from 2008-2009. J Clin Oncol 2012; 30: 4302-7. doi: 10.1200/JCO.2012.43.5297.
15. Benda RK, Yasuda G, Sethi A, Gabram SG, Hinerman RW, Mendenhall NP,. Breast boost: are we missing the target? Cancer 2003; 97: 905-9. doi: 10.1002/cncr.11142.
16. Vaidya JS, Joseph DJ, Tobias JS, et al,. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010; 376: 91-102. doi: 10.1016/S0140-6736(10)60837-9.
17. Houghton J, George WD, Cuzick J, et al,. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003; 362: 95-102.
18. Fisher B, Anderson S, Bryant J, et al,. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41. doi: 10.1056/NEJMoa022152.
19. Voogd AC, Nielsen M, Peterse JL, et al,. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001; 19: 1688-97.
20. American Cancer Society. Cancer facts and figures 2015. Available at: http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf. Updated 2015 (accessed October 1, 2015).
21. Baxter NN, Virnig BA, Durham SB, Tuttle TM,. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004; 96: 443-8.
22. Yao K, Czechura T, Liederbach E, et al,. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database. Ann Surg Oncol 2014; 21: 3457-65. doi: 10.1245/s10434-014-3717-3.
23. Stull TS, Catherine Goodwin M, Gracely EJ, et al,. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology. Ann Surg Oncol 2012; 19: 553-9. doi: 10.1245/s10434-011-1941-7.
24. Shah C, Wilkinson JB, Lyden M, Beitsch P, Vicini FA,. Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. Int J Radiat Oncol Biol Phys 2012; 82: e825-30. doi: 10.1016/j.ijrobp.2011.11.042.
25. Park SS, Grills IS, Chen PY, et al,. Accelerated partial breast irradiation for pure ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2011; 81: 403-8. doi: 10.1016/j.ijrobp.2010.05.030.
26. Israel PZ, Vicini F, Robbins AB, et al,. Ductal carcinoma in situ of the breast treated with accelerated partial breast irradiation using balloon-based brachytherapy. Ann Surg Oncol 2010; 17: 2940-4. doi: 10.1245/s10434-010-1044-x.
27. McHaffie DR, Patel RR, Adkison JB, Das RK, Geye HM, Cannon GM,. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features. Int J Radiat Oncol Biol Phys 2011; 81: 46-51. doi: 10.1016/j.ijrobp.2010.05.011.
28. Jeruss JS, Kuerer HM, Beitsch PD, Vicini FA, Keisch M,. Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Ann Surg Oncol 2011; 18: 65-71. doi: 10.1245/s10434-010-1192-z.
29. Holmes DR,. Intraoperative radiotherapy in breast conserving surgery. J Surg Oncol 2014; 110: 68-74. doi: 10.1002/jso.23620.
30. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, eds. Williams Obstetrics, 23rd edn. New York: McGraw-Hill, 2010. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ and Spong CY, eds. Chapter 16. Fetal Imaging (accessed August 21, 2012).
31. Wapnir IL, Dignam JJ, Fisher B, et al,. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011; 103: 478-88. doi: 10.1093/jnci/djr027.
32. Clarke M, Collins R, Darby S, et al,. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
33. Vicini F, Shah C, Ben Wilkinson J, Keisch M, Beitsch P, Lyden M,. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Ann Surg Oncol 2013; 20: 1275-81. doi: 10.1245/s10434-012-2694-7.
34. Chung A, Saouaf R, Scharre K, Phillips E,. The impact of MRI on the treatment of DCIS. Am Surg 2005; 71: 705-10.
35. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L,. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005; 11: 382-90. doi: 10.1111/j.1075-122X.2005.00121.x.
36. Hata T, Takahashi H, Watanabe K, et al,. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 2004; 198: 190-7. doi: 10.1016/j.jamcollsurg.2003.10.008.
37. Bedrosian I, Mick R, Orel SG, et al,. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003; 98: 468-73. doi: 10.1002/cncr.11490.
38. Schelfout K, Van Goethem M, Kersschot E, et al,. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004; 30: 501-7. doi: 10.1016/j.ejso.2004.02.003.
39. Plana MN, Carreira C, Muriel A, et al,. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol 2012; 22: 26-38. doi: 10.1007/s00330-011-2238-8.
40. Lehman CD, Gatsonis C, Kuhl CK, et al,. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: 1295-303.
41. Houssami N, Ciatto S, Macaskill P, et al,. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-58. doi: 10.1200/JCO.2007.15.2108.
42. Kuhl CK, Schrading S, Bieling HB, et al,. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007; 370: 485-92.
43. Tendulkar RD, Chellman-Jeffers M, Rybicki LA, et al,. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer 2009; 115: 1621-30. doi: 10.1002/cncr.24172.
44. Kuhr M, Wolfgarten M, Stolzle M, et al,. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011; 81: e541-6. doi: 10.1016/j.ijrobp.2011.04.035.
45. Godinez J, Gombos EC, Chikarmane SA, Griffin GK, Birdwell RL,. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. AJR Am J Roentgenol 2008; 191: 272-7. doi: 10.2214/AJR.07.3465.
46. Morakkabati-Spitz N, Leutner C, Schild H, Traeber F, Kuhl C,. Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol 2005; 15: 2010-7. doi: 10.1007/s00330-005-2755-4.
47. Cheng L, Swartz MD, Zhao H, et al,. Hazard of recurrence among women after primary breast cancer treatment-a 10 year follow-up using data for SEER-Medicare. Cancer Epidemiol Biomarkers Prev 2012; 21: 800-9.